Skip to main content
Top
Published in: Hormones 3/2020

01-09-2020 | Fertility | Review Article

Premature ovarian insufficiency in adolescence: a chance for early diagnosis?

Authors: Lina Michala, Katerina Stefanaki, Dimitris Loutradis

Published in: Hormones | Issue 3/2020

Login to get access

Abstract

Premature ovarian insufficiency (POI) is typically diagnosed when amenorrhea is combined with high gonadotrophins and hypoestrogenemia in a woman under 40 years of age, although, more rarely, POI can develop in adolescence and present with delayed puberty or amenorrhea, depending on the timing of follicular depletion or insult to the ovary. In a proportion of girls, the diagnosis may be made at an early stage of POI, presenting with abnormal uterine bleeding, when some follicular function is still retained. The natural history of POI in this group of patients is not clear; however, they could represent a subgroup with a unique opportunity for early intervention and thus the provision of fertility preservation options. While the etiology of POI in a large number of girls remains unknown, a growing number will be identified as carriers of genetic mutations, offering clinicians a yet greater opportunity to provide genetic counseling to other female family members. The aim of this review is to provide information regarding the etiology, diagnosis, and treatment of POI in adolescents while detailing the new options for fertility preservation when POI is diagnosed at an early stage.
Literature
1.
go back to reference Bakhsh H, Dei M, Bucciantini S, Balzi D, Bruni V (2015) Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density. Gynecol Endocrinol 31(1):65–69PubMedCrossRef Bakhsh H, Dei M, Bucciantini S, Balzi D, Bruni V (2015) Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density. Gynecol Endocrinol 31(1):65–69PubMedCrossRef
3.
go back to reference Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K et al (2014) Mutant cohesin in premature ovarian failure. N Engl J Med 370(10):943–949PubMedPubMedCentralCrossRef Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K et al (2014) Mutant cohesin in premature ovarian failure. N Engl J Med 370(10):943–949PubMedPubMedCentralCrossRef
4.
go back to reference Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y (1977) Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 39(4):1403–1409PubMedCrossRef Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y (1977) Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 39(4):1403–1409PubMedCrossRef
5.
go back to reference Insler V, Melmed H, Mashiah S, Monselise M, Lunenfeld B, Rabau E (1968) Functional classification of patients selected for gonadotropic therapy. Obstet Gynecol 32(5):620–626PubMed Insler V, Melmed H, Mashiah S, Monselise M, Lunenfeld B, Rabau E (1968) Functional classification of patients selected for gonadotropic therapy. Obstet Gynecol 32(5):620–626PubMed
6.
7.
go back to reference Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, Petersen JH et al (2012) Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod 27(3):861–866PubMedCrossRef Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, Petersen JH et al (2012) Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod 27(3):861–866PubMedCrossRef
8.
go back to reference Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K et al (2012) Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 38(4):315–321PubMedPubMedCentralCrossRef Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K et al (2012) Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 38(4):315–321PubMedPubMedCentralCrossRef
9.
go back to reference Gordon CM, Kanaoka T, Nelson LM (2015) Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr 27(4):511–519PubMedCrossRef Gordon CM, Kanaoka T, Nelson LM (2015) Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr 27(4):511–519PubMedCrossRef
10.
go back to reference Practice Committee of the American Society for Reproductive M (2004) Current evaluation of amenorrhea. Fertil Steril 82(1):266–272CrossRef Practice Committee of the American Society for Reproductive M (2004) Current evaluation of amenorrhea. Fertil Steril 82(1):266–272CrossRef
11.
go back to reference Baker VL (2013) Primary ovarian insufficiency in the adolescent. Curr Opin Obstet Gynecol 25(5):375–381PubMedCrossRef Baker VL (2013) Primary ovarian insufficiency in the adolescent. Curr Opin Obstet Gynecol 25(5):375–381PubMedCrossRef
12.
go back to reference Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG et al (2000) Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 15(1):197–202PubMedCrossRef Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG et al (2000) Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 15(1):197–202PubMedCrossRef
14.
go back to reference Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S et al (2005) Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 84(4):958–965PubMedCrossRef Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S et al (2005) Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 84(4):958–965PubMedCrossRef
15.
go back to reference Allen EG, Grus WE, Narayan S, Espinel W, Sherman SL (2014) Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Front Genet 5:260PubMedPubMedCentralCrossRef Allen EG, Grus WE, Narayan S, Espinel W, Sherman SL (2014) Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Front Genet 5:260PubMedPubMedCentralCrossRef
16.
go back to reference Kallio S, Aittomaki K, Piltonen T, Veijola R, Liakka A, Vaskivuo TE et al (2012) Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum Reprod 27(3):854–860PubMedCrossRef Kallio S, Aittomaki K, Piltonen T, Veijola R, Liakka A, Vaskivuo TE et al (2012) Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum Reprod 27(3):854–860PubMedCrossRef
17.
go back to reference Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH (2011) A validated model of serum anti-mullerian hormone from conception to menopause. PloS one. 6(7):e22024PubMedPubMedCentralCrossRef Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH (2011) A validated model of serum anti-mullerian hormone from conception to menopause. PloS one. 6(7):e22024PubMedPubMedCentralCrossRef
18.
go back to reference Miyoshi Y, Ohta H, Namba N, Tachibana M, Miyamura T, Miyashita E et al (2013) Low serum concentrations of anti-Mullerian hormone are common in 53 female childhood cancer survivors. Horm Res Paediatr 79(1):17–21PubMedCrossRef Miyoshi Y, Ohta H, Namba N, Tachibana M, Miyamura T, Miyashita E et al (2013) Low serum concentrations of anti-Mullerian hormone are common in 53 female childhood cancer survivors. Horm Res Paediatr 79(1):17–21PubMedCrossRef
20.
go back to reference Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18(11):2368–2374PubMedCrossRef Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18(11):2368–2374PubMedCrossRef
21.
go back to reference Lunding SA, Aksglaede L, Anderson RA, Main KM, Juul A, Hagen CP et al (2015) AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients. J Clin Endocrinol Metab 100(7):E1030–E1038PubMedCrossRef Lunding SA, Aksglaede L, Anderson RA, Main KM, Juul A, Hagen CP et al (2015) AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients. J Clin Endocrinol Metab 100(7):E1030–E1038PubMedCrossRef
22.
go back to reference van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH et al (2016) Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J Clin Oncol 34(28):3440–3450PubMedPubMedCentralCrossRef van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH et al (2016) Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J Clin Oncol 34(28):3440–3450PubMedPubMedCentralCrossRef
23.
go back to reference De Bellis A, Bellastella G, Falorni A, Aitella E, Barrasso M, Maiorino MI et al (2017) Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: from normal ovarian function to overt ovarian dysfunction. Eur J Endocrinol 177(4):329–337PubMedCrossRef De Bellis A, Bellastella G, Falorni A, Aitella E, Barrasso M, Maiorino MI et al (2017) Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: from normal ovarian function to overt ovarian dysfunction. Eur J Endocrinol 177(4):329–337PubMedCrossRef
24.
go back to reference Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM, Massin N, Maione L, Beau I et al (2017) Anti-Mullerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism/Kallmann syndrome: effects of recombinant human FSH. J Clin Endocrinol Metab 102(4):1102–1111PubMedCrossRef Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM, Massin N, Maione L, Beau I et al (2017) Anti-Mullerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism/Kallmann syndrome: effects of recombinant human FSH. J Clin Endocrinol Metab 102(4):1102–1111PubMedCrossRef
26.
go back to reference Michala L, Goswami D, Creighton SM, Conway GS (2008) Swyer syndrome: presentation and outcomes. BJOG 115(6):737–741PubMedCrossRef Michala L, Goswami D, Creighton SM, Conway GS (2008) Swyer syndrome: presentation and outcomes. BJOG 115(6):737–741PubMedCrossRef
27.
go back to reference Qin Y, Jiao X, Simpson JL, Chen ZJ (2015) Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 21(6):787–808PubMedPubMedCentralCrossRef Qin Y, Jiao X, Simpson JL, Chen ZJ (2015) Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 21(6):787–808PubMedPubMedCentralCrossRef
29.
go back to reference Rajaratnam A, Shergill J, Salcedo-Arellano M, Saldarriaga W, Duan X (2017) Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Res 6:2112PubMedPubMedCentralCrossRef Rajaratnam A, Shergill J, Salcedo-Arellano M, Saldarriaga W, Duan X (2017) Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Res 6:2112PubMedPubMedCentralCrossRef
30.
go back to reference Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J et al (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82(6):959–968PubMedCrossRef Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J et al (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82(6):959–968PubMedCrossRef
31.
go back to reference Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O et al (1996) Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 81(10):3722–3726PubMed Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O et al (1996) Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 81(10):3722–3726PubMed
33.
go back to reference Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E (2011) Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 34(2):357–366PubMedCrossRef Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E (2011) Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 34(2):357–366PubMedCrossRef
34.
go back to reference Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P et al (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27(2):159–166PubMedCrossRef Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P et al (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27(2):159–166PubMedCrossRef
35.
go back to reference De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K et al (2001) Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet 10(15):1591–1600PubMedCrossRef De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K et al (2001) Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet 10(15):1591–1600PubMedCrossRef
36.
go back to reference Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF et al (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72(6):1544–1550PubMedPubMedCentralCrossRef Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF et al (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72(6):1544–1550PubMedPubMedCentralCrossRef
37.
go back to reference Di Pasquale E, Beck-Peccoz P, Persani L (2004) Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75(1):106–111PubMedPubMedCentralCrossRef Di Pasquale E, Beck-Peccoz P, Persani L (2004) Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75(1):106–111PubMedPubMedCentralCrossRef
38.
go back to reference Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322(26):1829–1836PubMedCrossRef Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322(26):1829–1836PubMedCrossRef
39.
go back to reference Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus. J Rheumatol 26(5):1087–1093PubMed Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E (1999) Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus. J Rheumatol 26(5):1087–1093PubMed
40.
go back to reference La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A (2010) Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 22(4):277–282PubMedCrossRef La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A (2010) Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 22(4):277–282PubMedCrossRef
41.
42.
go back to reference Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimm 38(2-3):J266–J274CrossRef Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimm 38(2-3):J266–J274CrossRef
43.
go back to reference Carneiro-Sampaio M, Moraes-Vasconcelos D, Kokron CM, Jacob CM, Toledo-Barros M, Dorna MB et al (2013) Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol 33(4):716–724PubMedCrossRef Carneiro-Sampaio M, Moraes-Vasconcelos D, Kokron CM, Jacob CM, Toledo-Barros M, Dorna MB et al (2013) Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol 33(4):716–724PubMedCrossRef
44.
go back to reference Cabral de Sousa D, das Chagas Medeiros MM, Trindade Viana VS, Salani Mota RM (2005) Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto’s thyroiditis. Lupus. 14(8):618–624PubMedCrossRef Cabral de Sousa D, das Chagas Medeiros MM, Trindade Viana VS, Salani Mota RM (2005) Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto’s thyroiditis. Lupus. 14(8):618–624PubMedCrossRef
45.
go back to reference Hoek A, Schoemaker J, Drexhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18(1):107–134PubMed Hoek A, Schoemaker J, Drexhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18(1):107–134PubMed
46.
47.
go back to reference Euthymiopoulou K, Aletras AJ, Ravazoula P, Niarakis A, Daoussis D, Antonopoulos I et al (2007) Antiovarian antibodies in primary Sjogren’s syndrome. Rheumatol Int 27(12):1149–1155PubMedCrossRef Euthymiopoulou K, Aletras AJ, Ravazoula P, Niarakis A, Daoussis D, Antonopoulos I et al (2007) Antiovarian antibodies in primary Sjogren’s syndrome. Rheumatol Int 27(12):1149–1155PubMedCrossRef
48.
go back to reference Silva CA, Bonfa E, Ostensen M (2010) Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res 62(12):1682–1690CrossRef Silva CA, Bonfa E, Ostensen M (2010) Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res 62(12):1682–1690CrossRef
49.
go back to reference Trolle C, Hjerrild B, Cleemann L, Mortensen KH, Gravholt CH (2012) Sex hormone replacement in Turner syndrome. Endocrine. 41(2):200–219PubMedCrossRef Trolle C, Hjerrild B, Cleemann L, Mortensen KH, Gravholt CH (2012) Sex hormone replacement in Turner syndrome. Endocrine. 41(2):200–219PubMedCrossRef
51.
go back to reference Shah S, Forghani N, Durham E, Neely EK (2014) A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. Int J Pediatr Endocrinol 2014(1):12PubMedPubMedCentralCrossRef Shah S, Forghani N, Durham E, Neely EK (2014) A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. Int J Pediatr Endocrinol 2014(1):12PubMedPubMedCentralCrossRef
52.
go back to reference Gibbons WE, Moyer DL, Lobo RA, Roy S, Mishell DR Jr (1986) Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol 154(2):456–461PubMedCrossRef Gibbons WE, Moyer DL, Lobo RA, Roy S, Mishell DR Jr (1986) Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol 154(2):456–461PubMedCrossRef
53.
go back to reference Bjarnason K, Cerin A, Lindgren R, Weber T (1999) Adverse endometrial effects during long cycle hormone replacement therapy Scandinavian Long Cycle Study Group. Maturitas 32(3):161–170PubMedCrossRef Bjarnason K, Cerin A, Lindgren R, Weber T (1999) Adverse endometrial effects during long cycle hormone replacement therapy Scandinavian Long Cycle Study Group. Maturitas 32(3):161–170PubMedCrossRef
54.
go back to reference Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P (2012) Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 379(9815):588PubMedCrossRef Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P (2012) Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 379(9815):588PubMedCrossRef
55.
go back to reference Ernst E, Kjaersgaard M, Birkebaek NH, Clausen N, Andersen CY (2013) Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 49(4):911–914PubMedCrossRef Ernst E, Kjaersgaard M, Birkebaek NH, Clausen N, Andersen CY (2013) Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 49(4):911–914PubMedCrossRef
56.
go back to reference Donnez J, Dolmans MM (2015) Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 32(8):1167–1170PubMedPubMedCentralCrossRef Donnez J, Dolmans MM (2015) Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 32(8):1167–1170PubMedPubMedCentralCrossRef
57.
go back to reference Demeestere I, Simon P, Dedeken L, Moffa F, Tsepelidis S, Brachet C et al (2015) Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 30(9):2107–2109PubMedCrossRef Demeestere I, Simon P, Dedeken L, Moffa F, Tsepelidis S, Brachet C et al (2015) Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 30(9):2107–2109PubMedCrossRef
58.
go back to reference Wallace WH, Critchley HO, Anderson RA (2012) Optimizing reproductive outcome in children and young people with cancer. J Clin Oncol 30(1):3–5PubMedCrossRef Wallace WH, Critchley HO, Anderson RA (2012) Optimizing reproductive outcome in children and young people with cancer. J Clin Oncol 30(1):3–5PubMedCrossRef
Metadata
Title
Premature ovarian insufficiency in adolescence: a chance for early diagnosis?
Authors
Lina Michala
Katerina Stefanaki
Dimitris Loutradis
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Hormones / Issue 3/2020
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.1007/s42000-019-00141-5

Other articles of this Issue 3/2020

Hormones 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine